Researchers have recently found the enzyme that controls the metastasis of breast cancer.
The researchs at the University of California, San Diego School of Medicine, which was among the first to show a link to the spread of breast cancer, found the enzyme, called UBC13, in the breast cancer cells at two to three times the levels of normal healthy cells.
They also established that the enzyme regulated cancer cells' ability to transmit signals that stimulate cell growth and survival by regulating the activity of a protein called p38 which when "knocked down" prevents metastasis.
Xuefeng Wu, PhD, said that primary tumors are not normally lethal, the real danger were cancer cells that have successfully left the primary site, escaped through the blood vessels and invaded new organs, so their study showed that they might be able to block these cells and save lives.
Researchers have also defined a metastasis gene signature that could be used to evaluate clinical responses to cancer therapies that target the metastasis pathway.
The study is published in the current issue of PNAS.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
